Market Cap | ₹5,267Cr |
ROE | 157.88% |
P/E Ratio(TTM) | -15.38 |
EPS(TTM) | -10.55 |
P/B Ratio | 0.00 |
Dividend Yield | 0.00% |
Industry P/E | 35.59 |
Book Value | -6.69 |
Debt to Equity | -1.24 |
Face Value | 1 |
Parent Organisation | Sun Pharma Advanced Research Company Limited |
Managing Director | Mr. Dilip Shanghvi |
NSE Symbol | SPARC |
FUND NAME | AUM(%) |
---|---|
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth | 0.77% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
GMR Airports | NA (0.00%) | -248.57 | ||
JSW Infrastructure | NA (0.00%) | 43.30 | ||
Central Depository Services (India) | NA (0.00%) | 67.52 | ||
Aegis Vopak Terminals | NA (0.00%) | 272.55 |